论文部分内容阅读
世界制药业面临新药研发投资萎缩、新产品批准和上市数量减少、专利期满等问题,药物创制模式正在产生新的变革。如何使我国新药创制整体水平显著提高,推动医药产业由仿制为主向自主创新为主的战略性转变成为我国药物发展的重要课题。《从重大新药创制专项“十一五”计划探索我国新药创制研发网络的构建及其基本特征》一文,提出了构建由企业、大学院校、科研院所等行为主体之间相互联系、协同互动而形成的以知识创新和技术扩散为核心的新药创制研发网络的构想,对我国新药创制模式进行了有益
The pharmaceutical industry in the world is confronted with the shrinking investment in research and development of new drugs, the issue of new product approvals and listing drops, the expiration of patents, etc., and new patterns of drug creation are undergoing changes. How to make the overall level of innovation in medicine in our country significantly increase and promote the strategic transformation of the pharmaceutical industry from imitation to independent innovation as the major issue for the development of Chinese medicine? “From a major new drug creation special” “Eleventh Five-Year Plan” to explore the construction and basic characteristics of China’s new drug research and development network, "a text, proposed to build by the business, universities, research institutes and other actors interrelated, The idea of creating a research and development network of new drugs focusing on knowledge innovation and technology diffusion formed through coordinated and interaction has benefited the new drug creation model in our country